MTSS1 and chronic myelogenous leukemia, BCR-ABL1 positive: Ectopic expression of the CML driver oncogene Bcr−Abl in murine hematopoietic cells effected downregulation of Mtss1 in a manner partially sensitive to the ABL tyrosine kinase inhibitor imatinib [90].